Disease States | Eosinophilic Immune Dysfunction (EID)

References: 1. Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med. 2005;172:149-160. 2. Coumou H, Bel EH. Improving the diagnosis of eosinophilic asthma. Expert Rev Respir Med. 2016;10(10):1093-1103. 3. Trivedi SG, Lloyd CM. Eosinophils in the pathogenesis of allergic airway disease. Cell Mol Life Sci. 2007;64(10):1269-1289. 4. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343-373. 5. Data on File, REF-51332, AZPLP. 6. Rothenberg ME, Hogan SP. The eosinophil. Ann Rev Immunol. 2006;24:147-174. 7. Robinson D, Humbert M, Buhl R, et al. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017;47(2):161-175. 8. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323(15):1033-1039. 9. Price DB, Rigazio A, Campbell JK, et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med. 2015;3:849-858. 10. de Groot JC, Ten Brinke A, Bel EHD. Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Res. 2015;1(1):00024-2015. 11. Newby C, Agbetile J, Hargadon B, et al. Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma. J Allergy Clin Immunol. 2014;134:287-294. 12. Mukherjee M, Sehmi R, Nair P. Anti-IL5 therapy for asthma and beyond. World Allergy Organ J. 2014;7(1):32. 13. Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16(1):45-56. 14. Gandhi NA, Bennett BL, Graham NMH, et al. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15(1):35-50. 15. McBrien CN, Menzies-Gow A. The biology of eosinophils and their role in asthma. Front Med (Lausanne). 2017;4:93. 16. Fulkerson PC, Rothenberg ME. Targeting eosinophils in allergy, inflammation, and beyond. Nat Rev Drug Discov. 2013:12(2);117-129. 17. Hogan SP, Rosenberg HF, Moqbel R, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008:38(5);709-750. 18. de Groot JC, Storm H, Amelink M, et al. Clinical profile of patient with adult-onset eosinophilic asthma. ERJ Open Res. 2016;2(2):00100-2015. 19. Buhl R, Humbert M, Bjermer L, et al. Severe eosinophilic asthma: a roadmap to consensus. Eur Respir J. 2017;49(5).

EOSINOPHILIC IMMUNE DYSFUNCTIONACROSS INFLAMMATORY DISEASES

EOSINOPHILIC IMMUNE DYSFUNCTION
ACROSS INFLAMMATORY DISEASES